Literature DB >> 26462728

MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis.

Pedro M Machado1, Xenofon Baraliakos2, Désirée van der Heijde3, Jürgen Braun2, Robert Landewé4.   

Abstract

OBJECTIVES: To study the sequential relationship between MRI vertebral corner inflammation (VCI), vertebral corner fat deposition (VCFD) and the development/growth of radiographic syndesmophytes at the same vertebral corner (VC).
METHODS: Baseline, 24 and 102 weeks spinal MRIs were assessed for the presence/absence of VCI and VCFD. Anterior VCs of lateral radiographs of the cervical and lumbar spine (baseline and 102 weeks) were assessed for the development of new bone (syndesmophyte formation or syndesmophyte formation/growth combined). Data from 161 to 177 patients were analysed at the VC level using two-way and multilevel analyses adjusting for within-patient correlation and MRI reader (generalised estimating equations for binomial outcomes).
RESULTS: The presence of VCI (adjusted (adj) OR 1.75 to 1.98) as well as the presence of VCFD (adjOR 1.60 to 2.32) at any time point (TP) were significantly associated with the development of new bone. The combination of VCI and VCFD at the same VC increased the strength of the association, both for the sequential or simultaneous presence of VCI and VCFD across the three TPs (adjOR 2.12 to 2.73), as well as for the development of new VCFD preceded by VCI at a previous TP (adjOR 2.12 to 3.01). The complete absence of both VCI and VCFD across the three TPs 'protected' against new bone formation (adjOR 0.45 to 0.62). However, 40-66% of new bone still developed in VCs without MRI inflammation or fat degeneration at any of the three TPs.
CONCLUSIONS: Both VCI and VCFD contribute to new bone formation in ankylosing spondylitis (AS), especially if VCI precedes VCFD. However, VCI, VCFD and this particular sequence of events only partially explain the development of new bone in AS. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Ankylosing Spondylitis; Inflammation; Magnetic Resonance Imaging; Outcomes research; Spondyloarthritis

Mesh:

Substances:

Year:  2015        PMID: 26462728     DOI: 10.1136/annrheumdis-2015-208011

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

Review 1.  Structural Disease Progression in Axial Spondyloarthritis: Still a Cause for Concern?

Authors:  Barbara Neerinckx; Rik J Lories
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

Review 2.  Radiographic Progression in Ankylosing Spondylitis: From Prognostication to Disease Modification.

Authors:  Ismail Sari; Nigil Haroon
Journal:  Curr Rheumatol Rep       Date:  2018-11-08       Impact factor: 4.592

3.  Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study.

Authors:  Eun-Kyoung Park; Kyoungjune Pak; Ji-Heh Park; Keunyoung Kim; Seong-Jang Kim; In-Joo Kim; Geun-Tae Kim; Seung-Geun Lee
Journal:  Rheumatol Int       Date:  2017-02-02       Impact factor: 2.631

Review 4.  Mechanism of New Bone Formation in Axial Spondyloarthritis.

Authors:  Denis Poddubnyy; Joachim Sieper
Journal:  Curr Rheumatol Rep       Date:  2017-09       Impact factor: 4.592

5.  Spondyloarthritis: Low-dose CT for spondyloarthritis - a brilliant new chapter?

Authors:  Walter P Maksymowych; Robert G Lambert
Journal:  Nat Rev Rheumatol       Date:  2018-01-25       Impact factor: 20.543

Review 6.  Treat to Target in Axial Spondyloarthritis: Pros, Cons, and Future Directions.

Authors:  Jean W Liew; Maureen Dubreuil
Journal:  Rheum Dis Clin North Am       Date:  2020-05       Impact factor: 2.670

Review 7.  [Magnetic resonance imaging (MRI) diagnostics in axial spondyloarthritis].

Authors:  T Witte; X Baraliakos
Journal:  Z Rheumatol       Date:  2017-09       Impact factor: 1.372

Review 8.  Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

9.  Mono-exponential and bi-exponential model-based diffusion-weighted MR imaging and IDEAL-IQ sequence for quantitative evaluation of sacroiliitis in patients with ankylosing spondylitis.

Authors:  Cui Ren; Qiao Zhu; Huishu Yuan
Journal:  Clin Rheumatol       Date:  2018-10-07       Impact factor: 2.980

Review 10.  The role of imaging in the diagnosis and management of axial spondyloarthritis.

Authors:  Walter P Maksymowych
Journal:  Nat Rev Rheumatol       Date:  2019-10-07       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.